Transcatheter Aortic-Valve Replacement for Asymptomatic Severe Aortic Stenosis

Among patients with asymptomatic severe aortic stenosis, a strategy of early TAVR was superior to clinical surveillance in reducing the incidence of death, stroke, or unplanned hospitalization for cardiovascular causes. (Funded by Edwards Lifesciences; EARLY TAVR ClinicalTrials.gov number, NCT03042104.).

Authors

Institutions

Publication Details

Journal
New England Journal of Medicine
Published
2024-10-28
DOI
https://doi.org/10.1056/nejmoa2405880
Citations
208
Primary Topic
Cardiac Valve Diseases and Treatments
Type
article
Field-Weighted Citation Impact
83.62

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Transcatheter Aortic-Valve Replacement for Asymptomatic Severe Aortic Stenosis

William W. O’Neill, Jonathon A Leipsic, Philippe Généreux, Philippe Pîbarot et al.
208 citations
New England Journal of Medicine
Cardiac Valve Diseases and Treatments
83.62
article

Transcatheter Aortic-Valve Replacement for Asymptomatic Severe Aortic Stenosis

William W. O’Neill, Jonathon A Leipsic, Philippe Généreux, Philippe Pîbarot, Vasilis Babaliaros, Hemal Gada, Stuart Pocock, Björn Redfors, Molly Szerlip, Pinak Shah, Adnan K. Chhatriwalla, J. Bradley Oldemeyer, Kashish Goel, Allan Schwartz, Raj Makkar, David Daniels, Rebecca Tung Hahn, Brian R. Lindman, Clifford J. Kavinsky, Philipp Blanke, Thom Dahle, William F. Fearon, Heather Prince, Yanglu Zhao, David Jonathan Cohen, Martin B. Leon, Charles J. Davidson, Tej Sheth, Michael Mack
article en
208 citations

Abstract

Among patients with asymptomatic severe aortic stenosis, a strategy of early TAVR was superior to clinical surveillance in reducing the incidence of death, stroke, or unplanned hospitalization for cardiovascular causes. (Funded by Edwards Lifesciences; EARLY TAVR ClinicalTrials.gov number, NCT03042104.).

New England Journal of MedicineVol. 392(3)
Cornell University (US), Morristown Medical Center (US)
Edwards Lifesciences
Good health and well-being
Openalex Percentile: Top 0%
Cardiac Valve Diseases and Treatments
83.62
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.